We have synthesized 46 BVdU phosphoramidate derivatives 8–53 possessing improved cytotoxic activity against three tumour cell lines; murine leukemia (L1210), human CD4+ T-lymphocyte (CEM) and human cervical carcinoma (HeLa). Here, CD4 is linked to neoplasm.